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CASE REPORT Open Access
A double dilemma: treatment of stage IV
fetal twin-twin transfusion syndrome in the
setting of maternal recurrent venous
thromoembolism: a case report
Claire M. McCarthy1* , Alya al-Madhani1,2, Suzanne Smyth1, Nóirín E. Russell1, Ruwan Wimalasundera3 and
Keelin O’Donoghue1,4
Abstract
Background: Fetal conditions can pose significant challenges in the management of pregnancies complicated by
pre-existing maternal medical conditions.
Case presentation: We report a case of a 34-year-old woman with Stage IV Twin Twin Transfusion syndrome in
the presence of maternal recurrent complex venous thromboembolic disease. Following a previous pregnancy loss,
complicated by a third episode of thromboembolic disease, an inferior vena cava filter was placed. One month
later, a pregnancy was confirmed and subsequently identified as a monochorionic twin pregnancy. Twin-Twin
Transfusion syndrome was identified at 18 weeks’ gestation and progressed rapidly to Quintero Stage IV. In consultation
with a multi-disciplinary international team, fetoscopic laser photocoagulation was performed. The pregnancy progressed
to delivery of female infants at 33 weeks gestation, who have achieved all developmental milestones at 2 years of age.
Conclusions: We describe the multi-disciplinary effort to optimise the maternal condition to allow fetoscopic
laser photocoagulation and continued management of the maternal and fetal conditions to a successful pregnancy
outcome.
Keywords: Fetoscopy, Fetoscopic laser photocoagulation, Multi-disciplinary care, Twin twin transfusion syndrome, Venous
Thromboemobilic disease
Background
Monochorionic twin pregnancies are associated with an
increased risk of fetal morbidity and mortality due to
complications related to their chorionicity [1]. One of
the most common complications of monochorionic
pregnancy, and a reason for increased ultrasonographic
surveillance, is Twin-Twin Transfusion Syndrome (TTTS),
occurring in 10–20% of monozygous gestations [2]. Classi-
fication systems to categorise this condition, such as the
Quintero Classification aid in the diagnosis and formula-
tion of management plans [3].
As our population becomes more medically diverse,
women are entering pregnancy with medical conditions
which necessitate Obstetric Medicine expertise. Some
complications, such as cardiac and haematological con-
ditions can pose unique challenges to clinicians in both
obstetrics, medicine and surgery. We describe the case
of a woman diagnosed with stage IV TTTS in the setting
of recurrent venous thromboembolic (VTE) disease.
Case presentation
A 34 year old woman attended the perinatal medicine
clinic of a tertiary maternity hospital in her second preg-
nancy at 8 weeks gestation owing to a history of recur-
rent VTE disease, where a dating ultrasound diagnosed a
monochorionic twin pregnancy. She was a non-smoker,
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with no family history of VTE disease and a Body Mass
Index of less than 35 kg/m2.
Her medical history was significant for multiple diag-
noses of VTE disease over the preceding 10 years, des-
pite negative thrombophilia testing. Bilateral pulmonary
emboli (PE) were diagnosed following dental extraction
(in conjunction with oral contraceptive pill use), followed
7 years later by a left above-knee deep vein thrombosis
(DVT) and bilateral PE (in conjunction with a leg fracture
and long-haul flight). A third episode of DVT and PE was
identified at the time of a pregnancy loss. All episodes
were treated with therapeutic anticoagulation. Subse-
quently, a temporary inferior vena cava (IVC) filter was
inserted prior to an elective laparoscopic cholecystectomy,
yet on removal of this, a thrombus was identified requiring
further anticoagulation prior to removal.
One month following the IVC removal this lady had a
positive pregnancy test and prophylactic LMWH was
commenced followed by therapeutic LMWH on con-
firmation of a twin intrauterine pregnancy 2 weeks later.
This dose was adjusted according to maternal weight
and its efficacy was monitored by measuring trough and
peak anti-factor Xa levels. At 16 weeks of gestation,
anticoagulation was changed to twice daily enoxaparin
due to low levels of anti-factor Xa, which indicated a
rapid clearance of heparin.
As per guidance for monochorionic pregnancies [4], at
16 weeks gestation, fortnightly ultrasound surveillance
was commenced. At 18 weeks gestation, Quintero stage I
TTTS was diagnosed; Twin 1 was identified as the
recipient twin with polyhydramnios and a large bladder
while the donor twin (Twin 2) had oligohydramnios and
a small bladder. Umbilical artery Doppler measurements
for both twins were within normal limits at this time.
At this juncture, this lady was admitted to hospital for
multi-disciplinary team involvement. Given the early
gestation at which TTTS had developed and the poten-
tial for intervention, a permanent IVC filter was placed.
The decision to place an IVC filter was made by the
multi-disciplinary team due to the anticipated required
interruption or reduction in anticoagulation which
would increase the maternal risk of VTE disease at the
time of fetoscopic surgery. Within 4 days, scan findings
quickly progressed to Quintero stage IV TTTS. The
recipient twin developed grossly abnormal cardiac func-
tion with evidence of fetal hydrops. The donor twin had
anhydramnios, with an absent bladder and absent end
diastolic flow of the umbilical artery Doppler.
Opinion was sought from national and international
referral centres for consideration of laser photocoagula-
tion. Fetal and maternal procedure-related risks were
carefully considered and the potential risk of with-holding
fetal treatment in the maternal interest was also discussed.
The initial recommendations by a national centre for
fetoscopic surgery was that due to the maternal medical
co-morbidities and abnormal fetal cardiac function, with
associated poor prognosis, laser photocoagulation should
not be performed. Following re-assessment at the index
hospital, a referral was made to a fetal medicine unit in a
tertiary hospital in the United Kingdom (UK). Multidiscip-
linary discussion took place at this point with input from
maternal medicine and haematology, as well as detailed
patient and family counselling, discussed the risks of inter-
rupting therapeutic LMWH versus the possible benefits to
the fetuses of successful fetoscopic laser photocoagulation.
Following this, it was decided to perform surgery follow-
ing the interruption of therapeutic LMWH 24 h before
surgery and recommence this at 4 h post-procedure.
Following her return from the UK, subsequent fetal
surveillance scans were performed twice-weekly (assessing
amniotic fluid status and umbilical artery Doppler mea-
surements) which returned to normal pattern following
treatment. In view of the previous complications, ante-
natal corticosteroids were administered at 24 weeks gesta-
tion and close maternal and fetal surveillance continued
for the remainder of the pregnancy.
A detailed anatomical survey revealed persistent car-
diomegaly and evidence of impaired cardiac contractility
in the ex-recipient twin, however both fetal cardiac echo-
cardiograms were reassuringly structurally normal. Fetal
brain Magnetic Resonance Imaging (MRI) at 25 weeks
gestation revealed no neurological abnormalities in either
fetus.
Subsequently, pregnancy-induced hypertension was
diagnosed at 32 weeks gestation. At this point growth for
Twin 1 (ex-recipient) was 1.32 kg (less than the 2nd cen-
tile), with Twin 2 (ex-donor) noted to be 1.61 kg (11th
centile). Bladder size and umbilical artery Doppler stud-
ies were normal at this juncture. Serial surveillance con-
tinued, and 7 days later, Twin 1 had absent end diastolic
flow with abnormal ductus venosus flow. The decision
was made to proceed with caesarean delivery in the fetal
interests, and a multi-disciplinary team discussion includ-
ing maternal-fetal medicine, obstetrics, haematology, an-
aesthesiology and neonatology was conducted to plan
delivery. Later that day, 12 h following the therapeutic
dose of enoxaparin, and under spinal anaesthesia, two live
female infants were delivered, weighing 1.5 kg and 1.9 kg
respectively. They were transferred to the Special Care
Baby Unit in view of their antenatal course, prematurity
and low birth weights. Half-dose anticoagulation was
administered 6 h following the caesarean section, and full
therapeutic dosage was re-instituted 24 h post-operatively.
The post-partum period was otherwise uncomplicated.
She was reviewed by the haematology team at 6 weeks
postpartum and converted to apixaban twice daily. She
will now remain on life-long anticoagulation due to sig-
nificant risks of recurrent VTE disease. Both twins were
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discharged on Day 30 of life, with normal cranial ultra-
sounds and were achieving appropriate developmental
milestones at 6 weeks corrected age. Further follow-up
was performed until 2 years of age, when both girls were
maintaining their developmental milestones and were
discharged from paediatric care.
Discussion and conclusions
Our case describes a complex clinical situation of rapidly
progressive TTTS with an associated poor prognosis in
the absence of timely treatment, in a woman with a sig-
nificant medical co-morbidity. While this lady had a high
probability of suffering a further thromboembolic event
in isolation of fetal complications, treatment in order to
maximise fetal survival and minimise morbidity posed
further clinical dilemmas. Any surgical procedure posed
an increased haemorrhage risk, and concurrently propa-
gated the incidence of thromboembolic events, both of
which had maternal and fetal morbidity and mortality as a
consequence. Therefore, careful multidisciplinary manage-
ment was crucial to prevent deleterious consequences.
Despite being first described in 1687, the natural history
and aetiology of TTTS is largely unknown. It is associated
with a fetal mortality rate of 80–90% if untreated [5, 6]
and neurological handicap affecting 10–30% of co-twin
survivors following single twin intrauterine death [7].
Many different treatment strategies have been proposed
and practiced, but fetoscopic laser photocoagulation is
currently the primary treatment modality pursued [8].
Numerous studies have compared treatment strategies
for TTTS, assessing success as well as risk. A compari-
son of amnioreduction and laser ablation involving over
142 cases demonstrated that those undergoing laser
ablation were more likely to be free of major neuro-
logical complications at 6 months of age, with improved
survival of Quintero stage III and IV (66% versus 44%)
compared to the amnioreduction group [9].
Despite a relatively small body of evidence, fetoscopic
laser photocoagulation is considered by most experts to
be the best approach for stage II - IV TTTS in pregnan-
cies less than 26 weeks gestation [1, 8, 10]. In Ireland,
fetoscopic laser photocoagulation was reviewed in 2015,
with 105 cases performed over a 5 year period [11]. Dual
survival rates overall were 47%, and perinatal survival of
at least one infant was 75%; however only 5 (5%) cases
were classified and treated as stage IV. When compared
to international data, where stage IV procedures account
for a higher number of cases performed (27 (16.5%)}
[12], it was felt that a referral centre with more experience
provided increased survival and reduced neurological
morbidity in this scenario.
Examining the maternal factors in this case, VTE
disease is known to affect women in pregnancy and the
puerperium approximately 10 times more frequently
when compared to an age-matched non-pregnant cohort
of women [13]. The treatment of recurrent VTE disease
in pregnancy is complex and debated, with some authors
recommending retrievable filters over permanent filters
given the age profile of the pregnant woman coupled
with limited available follow-up data for this cohort [14].
Given the paucity of research in this area, treatment is
still largely experimental and needs further investigation,
potentially in the setting of a randomised controlled
trial; however both the feasibility and ethical acceptabil-
ity of this would make this difficult. In fields other than
obstetrics, the placement of IVC filters does remain an
unsubstantiated indication for the treatment of recurrent
VTE disease. In cases of recurrent VTE and prolonged
anti-coagulation, vitamin D and calcium supplementa-
tion may need to be considered, but further high grade
evidence would be required in order to make this a for-
mal recommendation [15, 16].
We describe a complex case with maternal and fetal
complications and considerations that evolved through-
out the pregnancy. Our case is unique, in that coupled
with the rapidly progressive early development of TTTS
to Quintero stage IV, this patient had a very high risk
for recurrent VTE entering pregnancy, and was success-
fully managed for both indications. In addition, multiple
pregnancy, polyhydramnios, antenatal and puerperal
surgical procedures combined with prolonged hospital-
isation increased our patients’ risk of recurrent VTE
disease significantly. Multidisciplinary and multi-centre
management was crucial to optimising maternal and
fetal outcomes. Haematological guidance on dosage of
anticoagulation and amendments to the regime at the
time of fetoscopic surgery and caesarean section were
crucial, and given the gravity of both situations required
timely and clear decision making and communication.
Through expert assessment of clinical complications
both in isolation and in tandem, we demonstrate how
complex high-risk and challenging medical scenarios can
be successfully managed, with assistance from the local, na-
tional and international expertise in time-critical scenarios.
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